Photo of Michael J. Barry,  MD

Michael J. Barry, MD

Massachusetts General Hospital

Massachusetts General Hospital

Michael J. Barry, MD

Massachusetts General Hospital

EDUCATIONAL TITLES

  • Professor, Medicine, Harvard Medical School
  • Chief, General Medicine Unit, Massachusetts General Hospital

DF/HCC PROGRAM AFFILIATION

Research Abstract

Dr. Barry's work focuses on outcomes research, which seeks to define the results of common strategies of care in terms that are most relevant to patients, particularly in terms of symptom burden and functional status. The content area of this research has been largely, but not exclusively, at the interface of primary care and urology. Using prostatic disease as a paradigm for other largely preference-driven medical problems requiring shared care between generalists and specialists, Dr. Barry has studied the diagnosis, prognosis, and treatment outcomes of this common set of disorders among older men. Methods employed have included decision analysis, analysis of the operating characteristics of diagnostic tests, development and validation of disease-specific health status measurements, predictive modeling, and technology assessment. A particular theme has been to develop methods to allow patients greater participation in their medical decisions, and to measure the impact of that involvement. The results of this work have had a direct impact on the treatment of prostatic diseases in the United States and worldwide.

Publications

Powered by Harvard Catalyst
  • El-Jawahri A, Mitchell SL, Paasche-Orlow MK, Temel JS, Jackson VA, Rutledge RR, Parikh M, Davis AD, Gillick MR, Barry MJ, Lopez L, Walker-Corkery ES, Chang Y, Finn K, Coley C, Volandes AE. A Randomized Controlled Trial of a CPR and Intubation Video Decision Support Tool for Hospitalized Patients. J Gen Intern Med 2015. PubMed
  • Hoffman RM, Koyama T, Albertsen PC, Barry MJ, Daskivich TJ, Goodman M, Hamilton AS, Stanford JL, Stroup AM, Potosky AL, Penson DF. Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized Prostate Cancer: Results from the Prostate Cancer Outcomes Study. J Gen Intern Med 2015. PubMed
  • Barry MJ. Incidentaloma Fatigue. JAMA Intern Med 2014. PubMed
  • Hoffman RM, Penson DF, Zietman AL, Barry MJ. Comparative effectiveness research in localized prostate cancer treatment. J Comp Eff Res 2013; 2:583-93. PubMed
  • Hayes JH, Barry MJ, McMahon PM. Observation versus initial treatment for prostate cancer. Ann Intern Med 2013; 159:574. PubMed
  • Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Lee PA, McMahon PM. Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis. Ann Intern Med 2013; 158:853-60. PubMed
  • Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, Holmberg L, Kantoff P, Konety BR, Murad MH, Penson DF, Zietman AL. Early Detection of Prostate Cancer: AUA Guideline. J Urol 2013. PubMed
  • Hoffman RM, Koyama T, Fan KH, Albertsen PC, Barry MJ, Goodman M, Hamilton AS, Potosky AL, Stanford JL, Stroup AM, Penson DF. Mortality After Radical Prostatectomy or External Beam Radiotherapy for Localized Prostate Cancer. Journal of the National Cancer Institute 2013. PubMed
  • Qaseem A, Barry MJ, Denberg TD, Owens DK, Shekelle P, . Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 2013. PubMed
  • Volandes AE, Paasche-Orlow MK, Mitchell SL, El-Jawahri A, Davis AD, Barry MJ, Hartshorn KL, Jackson VA, Gillick MR, Walker-Corkery ES, Chang Y, L√≥pez L, Kemeny M, Bulone L, Mann E, Misra S, Peachey M, Abbo ED, Eichler AF, Epstein AS, Noy A, Levin TT, Temel JS. Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer. J Clin Oncol 2013; 31:380-6. PubMed
  • Barry MJ, Andriole GL, Culkin DJ, Fox SH, Jones KM, Carlyle MH, Wilt TJ. Ascertaining cause of death among men in the Prostate Cancer Intervention Versus Observation Trial. Clin Trials 2013; 10:907-14. PubMed
  • Atlas SJ, Ashburner JM, Chang Y, Lester WT, Barry MJ, Grant RW. Population-based breast cancer screening in a primary care network. Am J Manag Care 2013; 18:821-9. PubMed
  • Hoffman RM, Barry MJ, Roberts RG, Sox HC. Reconciling primary care and specialist perspectives on prostate cancer screening. Ann Fam Med 2012; 10:568-71. PubMed
  • Barry MJ, Cantor A, Roehrborn CG. Relationships between Participants' International Prostate Symptom Score and BPH Impact Index Changes and Global Ratings of Change in a Trial of Phytotherapy for Men with Lower Urinary Tract Symptoms. J Urol 2012. PubMed
  • Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob BM, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T, . Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367:203-13. PubMed
  • McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE, Gonzalez CM, Kaplan SA, Penson DF, Ulchaker JC, Wei JT. Update on AUA Guideline on the Management of Benign Prostatic Hyperplasia. J Urol 2011. PubMed
  • Hoffman RM, Roberts RG, Barry MJ. Battling Prostate Cancer with 5-Alpha-Reductase Inhibitors: a Pyrrhic Victory? J Gen Intern Med 2011. PubMed
  • Hayes JH, Ollendorf DA, Pearson SD, Barry MJ, Kantoff PW, Stewart ST, Bhatnagar V, Sweeney CJ, Stahl JE, McMahon PM. Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA 2010; 304:2373-80. PubMed
  • Atlas SJ, Grant RW, Lester WT, Ashburner JM, Chang Y, Barry MJ, Chueh HC. A Cluster-Randomized Trial of a Primary Care Informatics-Based System for Breast Cancer Screening. J Gen Intern Med 2010. PubMed
  • Lee CN, Dominik R, Levin CA, Barry MJ, Cosenza C, O'Connor AM, Mulley AG, Sepucha KR. Development of instruments to measure the quality of breast cancer treatment decisions. Health Expect 2010; 13:258-72. PubMed
  • Barry MJ. The prostate cancer treatment bazaar: comment on "physician visits prior to treatment for clinically localized prostate cancer". Arch Intern Med 2010; 170:450-2. PubMed
  • Barry MJ, Schroeder AA. Cavernous sinus syndrome secondary to pituitary adenoma: A case report. Ear Nose Throat J 2010; 89:E1-3. PubMed
  • El-Jawahri A, Podgurski LM, Eichler AF, Plotkin SR, Temel JS, Mitchell SL, Chang Y, Barry MJ, Volandes AE. Use of video to facilitate end-of-life discussions with patients with cancer: a randomized controlled trial. J Clin Oncol 2010; 28:305-10. PubMed
  • Sepucha KR, Barry MJ. Making patient-centered cancer care a reality. Cancer 2009; 115:5610-1. PubMed
  • Hu JC, Gu X, Lipsitz SR, Barry MJ, D'Amico AV, Weinberg AC, Keating NL. Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 2009; 302:1557-64. PubMed
  • Hoffman RM, Couper MP, Zikmund-Fisher BJ, Levin CA, McNaughton-Collins M, Helitzer DL, VanHoewyk J, Barry MJ. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study). Arch Intern Med 2009; 169:1611-8. PubMed
  • Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Barry MJ, Zietman A, O'Leary M, Walker-Corkery E, Yao SL. Outcomes of localized prostate cancer following conservative management. JAMA 2009; 302:1202-9. PubMed
  • Dahl DM, Barry MJ, McGovern FJ, Chang Y, Walker-Corkery E, McDougal WS. A prospective study of symptom distress and return to baseline function after open versus laparoscopic radical prostatectomy. J Urol 2009; 182:956-65. PubMed
  • Kilbridge KL,Fraser G,Krahn M,Nelson EM,Conaway M,Bashore R,Wolf A,Barry MJ,Gong DA,Nease RF Jr,Connors AF. Lack of comprehension of common prostate cancer terms in an underserved population. J Clin Oncol 2009; 27:2015-21. PubMed
  • Barry MJ. Screening for prostate cancer--the controversy that refuses to die. N Engl J Med 2009; 360:1351-4. PubMed
  • Barry MJ,Mulley AJ Jr. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important? Journal of the National Cancer Institute 2009; 101:362-3. PubMed
  • Lester WT,Ashburner JM,Grant RW,Chueh HC,Barry MJ,Atlas SJ. Mammography FastTrack: an intervention to facilitate reminders for breast cancer screening across a heterogeneous multi-clinic primary care network. J Am Med Inform Assoc 2008; 16:187-95. PubMed
  • Wilt TJ,Brawer MK,Barry MJ,Jones KM,Kwon Y,Gingrich JR,Aronson WJ,Nsouli I,Iyer P,Cartagena R,Snider G,Roehrborn C,Fox S. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically locali Contemp Clin Trials 2008; 30:81-7. PubMed
  • Barry MJ. Screening for prostate cancer among men 75 years of age or older. N Engl J Med 2008; 359:2515-6. PubMed
  • Sepucha KR,Levin CA,Uzogara EE,Barry MJ,O'Connor AM,Mulley AG. Developing instruments to measure the quality of decisions: early results for a set of symptom-driven decisions. Patient Educ Couns 2008; 73:504-10. PubMed
  • Lu-Yao G,Albertsen PC,Stanford JL,Stukel TA,Walker-Corkery E,Barry MJ. Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up. J Gen Intern Med 2008; 23:1809-14. PubMed
  • Barry MJ. Editorial Comment on: Poor Overall Survival in Septa- and Octogenarian Patients after Radical Prostatectomy and Radiotherapy for Prostate Cancer: A Population-Based Study of 6183 Men. Eur Urol 2008; 54:116-7. PubMed
  • Barry MJ,Wescott PH,Reifler EJ,Chang Y,Moulton BW. Reactions of potential jurors to a hypothetical malpractice suit: alleging failure to perform a prostate-specific antigen test. J Law Med Ethics 2008; 36:396-402, 214. PubMed
  • Barry MJ,Kaufman DS,Wu CL. Case records of the Massachusetts General Hospital. Case 15-2008. A 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer. N Engl J Med 2008; 358:2161-8. PubMed
  • Barry MJ. Commentary: how serious is getting a diagnosis of prostate cancer? Oncologist 2008; 13:306-8. PubMed
  • Barry MJ, Link CL, McNaughton-Collins MF, McKinlay JB. Overlap of different urological symptom complexes in a racially and ethnically diverse, community-based population of men and women. BJU Int 2007; 101:45-51. PubMed
  • Hu JC, Link CL, McNaughton-Collins M, Barry MJ, McKinlay JB. The association of abuse and symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome: results from the Boston Area Community Health survey. J Gen Intern Med 2007; 22:1532-7. PubMed
  • Welch HG, Fisher ES, Gottlieb DJ, Barry MJ. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era. Journal of the National Cancer Institute 2007; 99:1395-400. PubMed
  • O'Connor AM, Bennett C, Stacey D, Barry MJ, Col NF, Eden KB, Entwistle V, Fiset V, Holmes-Rovner M, Khangura S, Llewellyn-Thomas H, Rovner DR. Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Making 2007; 27:554-74. PubMed
  • Hofherr SE, Mok H, Gushiken FC, Lopez JA, Barry MA. Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia. Hum Gene Ther 2007; 18:837-48. PubMed
  • Hayes JH, Barry MJ, Kantoff PW, Stahl JE. Prostate-specific antigen screening for prostate cancer: a decision-analytical perspective. BJU Int 2007; 100:486-8. PubMed
  • Barnato AE, Llewellyn-Thomas HA, Peters EM, Siminoff L, Collins ED, Barry MJ. Communication and decision making in cancer care: setting research priorities for decision support/patients' decision aids. Med Decis Making 2007; 27:626-34. PubMed
  • Kawachi MH, Bahnson RR, Barry M, Carroll PR, Carter HB, Catalona WJ, Epstein JI, Etzioni RB, Hemstreet GP 3rd, Howe RJ, Kopin JD, Lange PH, Lilja H, Mohler J, Moul J, Nadler RB, Patterson S, Pollack A, Presti JC, Stroup AM, Urban DA, Wake R, Wei JT. Prostate cancer early detection. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2007; 5:714-36. PubMed
  • Lu-Yao GL, Barry MJ, Albertsen PC, Yao SL. Outcomes of treatment vs observation of localized prostate cancer in elderly men. JAMA 2007; 297:1651; author reply 1652-3. PubMed
  • Barry MJ. Review: evidence from 2 low quality screening studies does not show a reduction in death from prostate cancer. Evid Based Med 2007; 12:40. PubMed
  • Barry MJ, Delorenzo MA, Walker-Corkery ES, Lucas FL, Wennberg DC. The rising prevalence of androgen deprivation among older American men since the advent of prostate-specific antigen testing: a population-based cohort study. BJU Int 2006; 98:973-8. PubMed
  • D'Amico AV, Barry MJ. Prostate cancer prevention and finasteride. J Urol 2006; 176:2010-2; discussion 2012-3. PubMed
  • Rodearmel SJ, Wyatt HR, Barry MJ, Dong F, Pan D, Israel RG, Cho SS, McBurney MI, Hill JO. A family-based approach to preventing excessive weight gain. Obesity (Silver Spring) 2006; 14:1392-401. PubMed
  • Fowler FJ, Barry MJ, Walker-Corkery B, Caubet JF, Bates DW, Lee JM, Hauser A, McNaughton-Collins M. The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes. J Gen Intern Med 2006; 21:715-21. PubMed
  • Hoffman RM, Barry MJ, Stanford JL, Hamilton AS, Hunt WC, Collins MM. Health outcomes in older men with localized prostate cancer: results from the Prostate Cancer Outcomes Study. Am J Med 2006; 119:418-25. PubMed
  • Chan EC, Barry MJ, Vernon SW, Ahn C. Brief report: physicians and their personal prostate cancer-screening practices with prostate-specific antigen. A national survey. J Gen Intern Med 2006; 21:257-9. PubMed
  • Chan EC, Barry MJ, Vernon SW, Ahn C. BRIEF REPORT: Physicians and Their Personal Prostate Cancer-screening Practices with Prostate-specific Antigen. J Gen Intern Med 2006. PubMed
  • Barry MJ. The PSA Conundrum. Arch Intern Med 2006; 166:7-8. PubMed
  • McNaughton-Collins M, Barry MJ. Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Am J Med 2005; 118:1331-9. PubMed
  • Bailey A, Martin ML, Girman C, McNaughton-Collins M, Barry MJ. Development of a multiregional United States Spanish version of the international prostate symptom score and the benign prostatic hyperplasia impact index. J Urol 2005; 174:1896-901; discussion 1901. PubMed
  • Barry MJ. Revisiting my personal decision about prostate-specific antigen testing in 2005. BJU Int 2005; 96:954-6. PubMed
  • Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Cancer Res 2005; 65:9789-98. PubMed
  • Barry MJ. Mortality rate from early prostate cancer increased 3 fold after 15 years following the diagnosis. ACP J Club 2005; 142:24. PubMed
  • McNaughton-Collins M, Fowler FJ, Caubet JF, Bates DW, Lee JM, Hauser A, Barry MJ. Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. Am J Med 2004; 117:719-25. PubMed
  • McNaughton-Collins M, Barry MJ, Caubet JF, Bates DW, Lee JM, Hauser A, Fowler FJ. VALIDITY OF PRIMARY CARE PATIENT SELF-REPORT OF ABNORMAL (BUT NOT CANCER) PROSTATE BIOPSY RESULTS. J Urol 2004; 172:2366-2368. PubMed
  • McNaughton-Collins M, Walker-Corkery E, Barry MJ. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000. J Natl Cancer Inst Monogr 2004. PubMed
  • Roberts TG, Barry M, Skarin AT. Mucoepidermoid carcinoma of the lung with t(11:19)(q21:p13): a link to new biology. Clin Adv Hematol Oncol 2005; 1:486-7; discussion 488. PubMed
  • Lu-Yao G, Albertsen PC, Stanford JL, Stukel TA, Walker-Corkery ES, Barry MJ. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ 2002; 325:740. PubMed
  • McNaughton Collins M, Barry MJ, Zietman A, Albertsen PC, Talcott JA, Walker Corkery E, Elliott DB, Fowler FJ. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region. Urology 2002; 60:628-33. PubMed
  • Fowler FJ, McNaughton Collins M, Walker Corkery E, Elliott DB, Barry MJ. The impact of androgen deprivation on quality of life after radical prostatectomy for prostate carcinoma. Cancer 2002; 95:287-95. PubMed
  • Wasson JH, Bubolz TA, Yao GL, Barry MJ. Prostate biopsies in men with limited life expectancy. Eff Clin Pract 2002; 5:137-42. PubMed
  • Barry MJ. NSAIDs and a lower risk of prostate cancer: causation or confounding? Mayo Clin Proc 2002; 77:217-8. PubMed
  • Welch G, Weinger K, Barry MJ. Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study. Urology 2002; 59:245-50. PubMed
  • Barry MJ. Health decision aids to facilitate shared decision making in office practice. Ann Intern Med 2002; 136:127-35. PubMed
  • Barry MJ. Fecal occult blood testing for colorectal cancer: a perspective. Ann Oncol 2002; 13:61-4. PubMed
  • Barry MJ. Evaluation of symptoms and quality of life in men with benign prostatic hyperplasia. Urology 2001; 58:25-32; discussion 32. PubMed
  • Barry MJ, Roehrborn CG. Benign prostatic hyperplasia. BMJ 2001; 323:1042-6. PubMed
  • Barry MJ, Albertsen PC, Bagshaw MA, Blute ML, Cox R, Middleton RG, Gleason DF, Zincke H, Bergstralh EJ, Jacobsen SJ. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer 2001; 91:2302-14. PubMed
  • Barry MJ. Clinical practice. Prostate-specific-antigen testing for early diagnosis of prostate cancer. N Engl J Med 2001; 344:1373-7. PubMed
  • Wasson JH, Bubolz TA, Lu-Yao GL, Walker-Corkery E, Hammond CS, Barry MJ. Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. For the Patient Outcomes Research Team for Prostatic Diseases. J Urol 2000; 164:1212-5. PubMed
  • Fowler FJ, McNaughton Collins M, Albertsen PC, Zietman A, Elliott DB, Barry MJ. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. JAMA 2000; 283:3217-22. PubMed
  • McNaughton Collins M, Stafford RS, Barry MJ. Age-specific patterns of prostate-specific antigen testing among primary care physician visits. J Fam Pract 2000; 49:169-72. PubMed
  • Hoffman RM, Lewis CL, Pignone MP, Couper MP, Barry MJ, Elmore JG, Levin CA, Van Hoewyk J, Zikmund-Fisher BJ. Decision-making processes for breast, colorectal, and prostate cancer screening: the DECISIONS survey. Med Decis Making 2010; 30:53S-64S. PubMed
  • Volandes AE, Barry MJ, Chang Y, Paasche-Orlow MK. Improving decision making at the end of life with video images. Med Decis Making 2010; 30:29-34. PubMed
  • Collins MM, O'Leary MP, Barry MJ. Prevalence of bothersome genitourinary symptoms and diagnoses in younger men on routine primary care visits. Urology 1998; 52:422-7. PubMed
  • Wasson JH, Fowler FJ, Barry MJ. Androgen deprivation therapy for asymptomatic advanced prostate cancer in the prostate specific antigen era: a national survey of urologist beliefs and practices. J Urol 1998; 159:1993-6; discussion 1996-7. PubMed
  • Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I. High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia. Am J Med 1998; 104:517-25. PubMed
  • Fowler FJ, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, Barry MJ. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med 1998; 104:526-32. PubMed
  • Collins MM, Stafford RS, O'Leary MP, Barry MJ. How common is prostatitis? A national survey of physician visits. J Urol 1998; 159:1224-8. PubMed
  • Collins MM, Fowler FJ, Roberts RG, Oesterling JE, Annas GJ, Barry MJ. Medical malpractice implications of PSA testing for early detection of prostate cancer. J Law Med Ethics 2000; 25:234-42, 230. PubMed
  • McNaughton Collins M, Ransohoff DF, Barry MJ. Early detection of prostate cancer. Serendipity strikes again. JAMA 1997; 278:1516-9. PubMed
  • Barry MJ, Fowler FJ, Bin L, Oesterling JE. A nationwide survey of practicing urologists: current management of benign prostatic hyperplasia and clinically localized prostate cancer. J Urol 1997; 158:488-91; discussion 492. PubMed
  • Coley CM, Barry MJ, Fleming C, Fahs MC, Mulley AG. Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians. Ann Intern Med 1997; 126:468-79. PubMed
  • Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians. Ann Intern Med 1997; 126:394-406. PubMed
  • Barry MJ, Fowler FJ, Bin L, Pitts JC, Harris CJ, Mulley AG. The natural history of patients with benign prostatic hyperplasia as diagnosed by North American urologists. J Urol 1997; 157:10-4; discussion 14-5. PubMed
  • Collins MM, Barry MJ. Controversies in prostate cancer screening. Analogies to the early lung cancer screening debate. JAMA 1996; 276:1976-9. PubMed
  • Lepor H, Williford WO, Barry MJ, Brawer MK, Dixon CM, Gormley G, Haakenson C, Machi M, Narayan P, Padley RJ. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group. N Engl J Med 1996; 335:533-9. PubMed
  • Fowler FJ, Barry MJ, Lu-Yao G, Wasson JH, Bin L. Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol 1996; 14:2258-65. PubMed
  • O'Leary MP, Fowler FJ, Lenderking WR, Barber B, Sagnier PP, Guess HA, Barry MJ. A brief male sexual function inventory for urology. Urology 1995; 46:697-706. PubMed
  • Barry MJ, Fowler FJ, Chang Y, Liss CL, Wilson H, Stek M. The American Urological Association symptom index: does mode of administration affect its psychometric properties? J Urol 1995; 154:1056-9. PubMed
  • Barry MJ, Fowler FJ, Mulley AG, Henderson JV, Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care 1995; 33:771-82. PubMed
  • Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team. JAMA 1993; 269:2650-8. PubMed
Hide